A5060806470- Mitochondrial Function and Pathology
- Long-Term Effects of COVID-19
- Metabolism and Genetic Disorders
- Cardiomyopathy and Myosin Studies
- Peripheral Neuropathies and Disorders
- Genetic Neurodegenerative Diseases
- Neurogenetic and Muscular Disorders Research
- Muscle Physiology and Disorders
- Atrial Fibrillation Management and Outcomes
- Takotsubo Cardiomyopathy and Associated Phenomena
- Cardiovascular Function and Risk Factors
- SARS-CoV-2 and COVID-19 Research
- Neurological and metabolic disorders
- Infectious Encephalopathies and Encephalitis
- COVID-19 Clinical Research Studies
- Parkinson's Disease Mechanisms and Treatments
- ATP Synthase and ATPases Research
- Retinal and Optic Conditions
- Neurological disorders and treatments
- Epilepsy research and treatment
- Cardiac Arrhythmias and Treatments
- Hereditary Neurological Disorders
- RNA modifications and cancer
- Neurological diseases and metabolism
- Acute Ischemic Stroke Management
Medical University of Vienna
2006-2025
Austrian Competence Centre of Food Safety
2020-2024
Research Center of Neurology
2022-2024
Laboratoire de Biochimie
2023-2024
Universidade Federal de São Paulo
2017-2024
Neurology, Inc
2024
Creative Commons
2019-2024
Amsterdam UMC Location University of Amsterdam
2024
University of Lisbon
2024
University of Monastir
2021-2024
Background and purpose Guidelines on monogenic cerebral small‐vessel disease (cSVD) diagnosis management are lacking. Endorsed by the Stroke Neurogenetics Panels of European Academy Neurology, a group experts has provided recommendations selected cSVDs, i.e. autosomal dominant arteriopathy with subcortical infarcts leukoencephalopathy (CADASIL), recessive (CARASIL), High Temperature Requirement A Serine Peptidase 1 (HTRA1), cathepsin‐A‐related strokes (CARASAL), pontine microangiopathy...